공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 암백신 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년)

Cancer Vaccines Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028941
페이지 정보 영문 175 Pages
가격
US $ 5,000 ₩ 5,987,000 PDF (Single User License)
US $ 7,500 ₩ 8,981,000 PDF (Site License)
US $ 10,000 ₩ 11,975,000 PDF (Enterprise License)


세계의 암백신 시장 : COVID-19에 의한 성장 및 변화 전망(-2030년) Cancer Vaccines Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암백신(Cancer Vaccines) 시장을 조사했으며, 시장의 정의와 개요, 코로나19(COVID-19) 및 기타 시장 영향요인 분석, 시장 규모 추이와 예측, 종류·기술·암구분·최종사용자·지역/주요 국가 등 각종 구분별 분석, 경쟁 환경, 주요 기업 개요, 향후 전망 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 COVID-19의 영향

제5장 시장 규모 및 성장 예측

  • 시장 규모 추이와 예측
  • 성장 촉진요인
  • 성장 억제요인

제6장 시장 분석과 예측 : 각종 구분별

  • 유형별
    • 예방용 암백신
    • 치료용 암백신
  • 기술별
    • 수상세포(DC) 암백신
    • 재조합 암백신
    • 항원/항원보강제 암백신
    • 전세포 암백신
    • 바이러스 벡터/DNA 암백신
  • 암 구분별
    • 전립선암
    • 자궁경부암
    • 대장암
    • 인두암
    • 기타
  • 최종사용자별
    • 암 치료센터
    • 연구기관

제7장 시장 분석과 예측 : 지역/국가별

제8장 아시아태평양 시장 분석과 예측

  • 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 이니셔티브, 법규제, 기관&협회, 조세, 투자, 주요 기업
  • 시장 분석과 예측 : 유형별
  • 시장 분석과 예측 : 기술별

제9장 중국 시장 분석과 예측

제10장 인도 시장 분석과 예측

제11장 일본 시장 분석과 예측

제12장 호주 시장 분석과 예측

제13장 인도네시아 시장 분석과 예측

제14장 한국 시장 분석과 예측

제15장 서유럽 시장 분석과 예측

제16장 영국 시장 분석과 예측

제17장 독일 시장 분석과 예측

제18장 프랑스 시장 분석과 예측

제19장 동유럽 시장 분석과 예측

제20장 러시아 시장 분석과 예측

제21장 북미 시장 분석과 예측

제22장 미국 시장 분석과 예측

제23장 남미 시장 분석과 예측

제24장 브라질 시장 분석과 예측

제25장 중동 시장 분석과 예측

제26장 아프리카 시장 분석과 예측

제27장 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • GlaxoSmithKline
    • Merck
    • Aduro Biotech
    • Astrazeneca Plc
    • Dendreon

제28장 암백신 파이프라인 분석

제28장 주요 인수합병(M&A)

제29장 향후 전망과 잠재성 분석

제30장 부록

LSH 21.10.06

Cancer Vaccines Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cancer vaccines market.

This report focuses on cancer vaccines market which is experiencing strong growth. The report gives a guide to the cancer vaccines market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cancer vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cancer Vaccines market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cancer vaccines market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer vaccines market section of the report gives context. It compares the cancer vaccines market with other segments of the cancer vaccines market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer vaccines indicators comparison.

Scope

Markets Covered: 1) By Type: Preventive Cancer Vaccines; Therapeutic Cancer Vaccines

2) By Technology: Dendritic Cells (DC) Cancer Vaccines; Recombinant Cancer Vaccines; Antigen/Adjuvant Cancer Vaccines; Whole Cell Cancer Vaccines; Viral Vector & DNA Cancer Vaccines

3) By Cancer Type: Prostate; Cervical; Colorectal; Throat; Others

4) By End-User: Cancer Treatment Centers; Research Institutes

Companies Mentioned: GlaxoSmithKline; Merck; Aduro Biotech; Astrazeneca Plc; Dendreon

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Cancer Vaccines Market Characteristics

3. Cancer Vaccines Market Trends And Strategies

4. Impact Of COVID-19 On Cancer Vaccines

5. Cancer Vaccines Market Size And Growth

  • 5.1. Global Cancer Vaccines Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cancer Vaccines Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cancer Vaccines Market Segmentation

  • 6.1. Global Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines
  • 6.2. Global Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Dendritic Cells (DC) Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines
  • Whole Cell Cancer Vaccines
  • Viral Vector & DNA Cancer Vaccines
  • 6.3. Global Cancer Vaccines Market, Segmentation By Cancer Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prostate
  • Cervical
  • Colorectal
  • Throat
  • Others
  • 6.4. Global Cancer Vaccines Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer Treatment Centers
  • Research Institutes

7. Cancer Vaccines Market Regional And Country Analysis

  • 7.1. Global Cancer Vaccines Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Cancer Vaccines Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Cancer Vaccines Market

  • 8.1. Asia-Pacific Cancer Vaccines Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Cancer Vaccines Market

  • 9.1. China Cancer Vaccines Market Overview
  • 9.2. China Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Cancer Vaccines Market

  • 10.1. India Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Cancer Vaccines Market

  • 11.1. Japan Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Cancer Vaccines Market

  • 12.1. Australia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Cancer Vaccines Market

  • 13.1. Indonesia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Cancer Vaccines Market

  • 14.1. South Korea Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Cancer Vaccines Market

  • 15.1. Western Europe Cancer Vaccines Market Overview
  • 15.2. Western Europe Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Cancer Vaccines Market

  • 16.1. UK Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Cancer Vaccines Market

  • 17.1. Germany Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Cancer Vaccines Market

  • 18.4. France Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Cancer Vaccines Market

  • 19.1. Eastern Europe Cancer Vaccines Market Overview
  • 19.2. Eastern Europe Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Cancer Vaccines Market

  • 20.1. Russia Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Cancer Vaccines Market

  • 21.1. North America Cancer Vaccines Market Overview
  • 21.2. North America Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Cancer Vaccines Market

  • 22.1. USA Cancer Vaccines Market Overview
  • 22.2. USA Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Cancer Vaccines Market

  • 23.1. South America Cancer Vaccines Market Overview
  • 23.2. South America Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Cancer Vaccines Market

  • 24.1. Brazil Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Cancer Vaccines Market

  • 25.1. Middle East Cancer Vaccines Market Overview
  • 25.2. Middle East Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Cancer Vaccines Market

  • 26.1. Africa Cancer Vaccines Market Overview
  • 26.2. Africa Cancer Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Cancer Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Cancer Vaccines Market Competitive Landscape And Company Profiles

  • 27.1. Cancer Vaccines Market Competitive Landscape
  • 27.2. Cancer Vaccines Market Company Profiles
    • 27.2.1. GlaxoSmithKline
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Aduro Biotech
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Astrazeneca Plc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Dendreon
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Cancer Vaccines Pipeline Analysis

29. Key Mergers And Acquisitions In The Cancer Vaccines Market

30. Cancer Vaccines Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q